MCRB – seres therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Seres Therapeutics, Inc. (NASDAQ: MCRB) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
This Biotech Startup Raised $12.5 Million To Find Bacteria That Help Fight Cancer [Forbes]
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Seres Therapeutics, Inc. (NASDAQ: MCRB) had its "market perform" rating re-affirmed by analysts at Oppenheimer Holdings Inc..
Seres Therapeutics, Inc. (NASDAQ: MCRB) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $15.00 to $10.00. They now have a "buy" rating on the stock.
Form 4 Seres Therapeutics, Inc. For: May 14 Filed by: von Moltke Lisa
Form 4 Seres Therapeutics, Inc. For: May 15 Filed by: Shaff Eric D.
Form 4 Seres Therapeutics, Inc. For: May 15 Filed by: Young Teresa L.
Form 4 Seres Therapeutics, Inc. For: May 15 Filed by: Henn Matthew R.
Form 4 Seres Therapeutics, Inc. For: May 15 Filed by: Ege David S.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.